Oscar Health (NYSE:OSCR) Releases Earnings Results, Misses Estimates By $0.07 EPS

Oscar Health (NYSE:OSCR - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07), Zacks reports. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Price Performance

OSCR traded down $0.98 during trading on Thursday, reaching $14.78. The stock had a trading volume of 7,383,854 shares, compared to its average volume of 3,866,028. Oscar Health has a 1-year low of $13.05 and a 1-year high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a 50 day moving average of $15.14 and a two-hundred day moving average of $16.83. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of -246.21, a price-to-earnings-growth ratio of 0.67 and a beta of 1.73.

Insiders Place Their Bets

In related news, Vice Chairman Joshua Kushner purchased 276,040 shares of Oscar Health stock in a transaction dated Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now directly owns 5,031,262 shares of the company's stock, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the transaction, the director now directly owns 89,512 shares in the company, valued at $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on OSCR. Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.